202 related articles for article (PubMed ID: 33262121)
1. Orodispersible and transmucosal alternative medications for symptom control in adults.
Sutherland AE; Presland M; Harrop E; Carey M; Miller M; Wong ICKC
BMJ Support Palliat Care; 2022 Sep; 12(3):305-315. PubMed ID: 33262121
[TBL] [Abstract][Full Text] [Related]
2. Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic.
Lam JKW; Cheung CCK; Chow MYT; Harrop E; Lapwood S; Barclay SIG; Wong ICK
Adv Drug Deliv Rev; 2020; 160():234-243. PubMed ID: 33137363
[TBL] [Abstract][Full Text] [Related]
3. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.
Poolman M; Roberts J; Wright S; Hendry A; Goulden N; Holmes EA; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; O'Connor J; Foster B; Reymond L; Healy S; Lewis P; Wee B; Johnstone R; Roberts R; Parkinson A; Roberts S; Wilkinson C
Health Technol Assess; 2020 May; 24(25):1-150. PubMed ID: 32484432
[TBL] [Abstract][Full Text] [Related]
4. Anticipatory prescribing in community end-of-life care in the UK and Ireland during the COVID-19 pandemic: online survey.
Antunes B; Bowers B; Winterburn I; Kelly MP; Brodrick R; Pollock K; Majumder M; Spathis A; Lawrie I; George R; Ryan R; Barclay S
BMJ Support Palliat Care; 2020 Sep; 10(3):343-349. PubMed ID: 32546559
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK.
Dick A; Keady S; Mohamed F; Brayley S; Thomson M; Lloyd BW; Heuschkel R; Afzal NA
Aliment Pharmacol Ther; 2003 Feb; 17(4):571-5. PubMed ID: 12622766
[TBL] [Abstract][Full Text] [Related]
7. CARer-ADministration of as-needed subcutaneous medication for breakthrough symptoms in homebased dying patients (CARiAD): study protocol for a UK-based open randomised pilot trial.
Poolman M; Roberts J; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; Foster B; O'Connor J; Reymond L; Healy S; Roberts R; Wee B; Lewis P; Johnstone R; Roberts S; Holmes E; Wright S; Hendry A; Wilkinson C
Trials; 2019 Feb; 20(1):105. PubMed ID: 30732624
[TBL] [Abstract][Full Text] [Related]
8. The role and response of primary healthcare services in the delivery of palliative care in epidemics and pandemics: A rapid review to inform practice and service delivery during the COVID-19 pandemic.
Mitchell S; Maynard V; Lyons V; Jones N; Gardiner C
Palliat Med; 2020 Oct; 34(9):1182-1192. PubMed ID: 32736494
[TBL] [Abstract][Full Text] [Related]
9. Healthcare users' experiences of communicating with healthcare professionals about children who have life-limiting conditions: a qualitative systematic review protocol.
Ekberg S; Bradford N; Herbert A; Danby S; Yates P
JBI Database System Rev Implement Rep; 2015 Nov; 13(11):33-42. PubMed ID: 26657462
[TBL] [Abstract][Full Text] [Related]
10. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
11. Palliative care at home: carers and medication management.
Anderson BA; Kralik D
Palliat Support Care; 2008 Dec; 6(4):349-56. PubMed ID: 19006589
[TBL] [Abstract][Full Text] [Related]
12. A mixed-methods systematic review and meta-analysis of barriers and facilitators to paediatric symptom management at end of life.
Greenfield K; Holley S; Schoth DE; Harrop E; Howard RF; Bayliss J; Brook L; Jassal SS; Johnson M; Wong I; Liossi C
Palliat Med; 2020 Jun; 34(6):689-707. PubMed ID: 32228216
[TBL] [Abstract][Full Text] [Related]
13. Healthcare professionals' views of the use of oral morphine and transmucosal diamorphine in the management of paediatric breakthrough pain and the feasibility of a randomised controlled trial: A focus group study (DIPPER).
Jamieson L; Harrop E; Johnson M; Liossi C; Mott C; Oulton K; Skene SS; Wong IC; Howard RF
Palliat Med; 2021 Jun; 35(6):1118-1125. PubMed ID: 33845654
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of transmucosal sedation for special needs populations in the ambulatory care setting.
Tetef S
AORN J; 2014 Dec; 100(6):651-68; quiz 667-9. PubMed ID: 25453684
[TBL] [Abstract][Full Text] [Related]
15. Good end-of-life care in nursing home according to the family carers' perspective: A systematic review of qualitative findings.
Gonella S; Basso I; De Marinis MG; Campagna S; Di Giulio P
Palliat Med; 2019 Jun; 33(6):589-606. PubMed ID: 30969160
[TBL] [Abstract][Full Text] [Related]
16. Seizing the Opportunity: Exploring Barriers to Use of Transmucosal Midazolam in Hospice Patients.
Perna SJ; Rhinewalt JM; Currie ER
J Palliat Med; 2018 May; 21(5):674-677. PubMed ID: 29303424
[TBL] [Abstract][Full Text] [Related]
17. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
18. Managing end of life medications at home--accounts of bereaved family carers: a qualitative interview study.
Payne S; Turner M; Seamark D; Thomas C; Brearley S; Wang X; Blake S; Milligan C
BMJ Support Palliat Care; 2015 Jun; 5(2):181-8. PubMed ID: 25256259
[TBL] [Abstract][Full Text] [Related]
19. An open-label clinical trial of oral transmucosal haloperidol and oral transmucosal olanzapine in the treatment of terminal delirium at home.
Lyu XJ; Kan AD; Chong PH; Lin K; Koh YH; Yeo ZZ
Trials; 2022 Apr; 23(1):311. PubMed ID: 35422053
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
